Perrine Lhuillier

Neurological and psychiatric disorders are rising sharply due to aging populations and the ongoing mental health crisis, placing unprecedented strain on already overburdened healthcare systems. Indeed, the WHO reports that neurological conditions are the leading cause of disability adjusted life years (DALYs) and already account for about 9 million deaths. Currently, neuropsychological evaluations still rely on paper-and-pencil tests that must be scored and reported manually - a process that takes the clinician up to two hours per patient. As the demand for such evaluations increases, this inefficiency worsens the existing shortage of neuropsychologists, resulting in diagnostic delays. Manual scoring also introduces variability and human error, which increase the risk of misdiagnosis, with serious consequences for patient care and treatment outcomes. 

Building on research conducted by the UZH Chair for Methods of Plasticity Research under the leadership of Prof. Dr. Nicolas Langer, neurodAIgnostics addresses these challenges by leveraging AI to increase the speed and precision of cognitive tests without changing trusted workflows. By automating scoring and report generation, neurodAIgnostic solutions reduce assessment time by more than half, delivers standardized, objective and reproducible results, while also unlocking new diagnostic markers through advanced sensing technologies. The result is earlier, more accurate diagnosis, reduced waiting lists, and higher patient throughput.  

The Entrepreneur Fellowship is instrumental to translate the team’s vision into a viable enterprise. The team will leverage financial resources and expert advice to shape business strategy, sharpen financial planning, and systematize operational processes, ultimately creating a robust foundation for growth and long-term innovation. Core milestones include securing regulatory approvals, raising seed funding, and executing pilot projects in clinics across the DACH region and beyond to advance product development and full market validation.

Affiliation: Prof. Dr. Nicolas Langer 
Start date: 1.09.25